Search Tag: cardiovascular disease

Cardiology Management

#ESCCongress: Findings from DAPA-CKD Trial

2020 30 Aug

The main results of the DAPA-CK trial were presented today at ESC Congress 2020. Findings showed that dapagliflozin reduces the risk of kidney failure, death from cardiovascular causes or heart failure hospitalisation and all-cause mortality in chronic kidney disease patients with or without type 2 diabetes. The goal of the DAPA-CKD trial was to... Read more

Health Management

Volume 20 - Issue 6, 2020

2020 29 Aug

Change content default value Read more

Health Management

Smart Diagnostics

2020 29 Aug

Diagnostics in healthcare has always been an area that has been downplayed. That is probably why inaccurate and/or delayed diagnosis is something that has persisted in this field for decades. It is a systemic problem that continues to have an impact on patient treatment and outcomes.  The solution could potentially lie in smart diagnostics... Read more

Health Management

Influence of Biotin Nutritional Supplementation on Laboratory Testing: Sex and Gender Impact

2020 29 Aug

High dose biotin supplementation is most common among females and may cause faulty immunoassay results that delay diagnosis and treatment of serious medical conditions. Key Points Biotin, also known as Vitamin B7, is an essential micronutrient that widely functions in the metabolic processing of amino acids, fats, and carbohydrates.... Read more

Cardiology Management

Ageing Heart Cells Increase Susceptibility of Older Patients to Severe COVID-19

2020 20 Aug

Genes that play an important role in allowing SARS-CoV-2 to invade heart cells become more active with age, according to research published today in the  Journal of Molecular and Cellular Cardiology . The findings could help explain why age is major risk factor for dying from COVID-19, with people over 70 years at greatest risk, and why the disease... Read more

Cardiology Management

The Cardiovascular Legacy of COVID-19

2020 09 Jul

As the world continues to struggle through the COVID-19 pandemic, an area of concern is the increasing burden of cardiovascular disease. CVD was already an area of concern before the coronavirus outbreak since it is the leading cause of death in the world. However, the pandemic has made the outlook for CVD even more gloomy.   Approximately 60... Read more

Cardiology Management

COVID-19 and New-Onset Atrial Fibrillation

2020 09 Jul

During the COVID-19 pandemic lockdowns, all non-critical appointments in hospitals have been postponed, and GPs and private specialists are only seeing patients with the most urgent needs. The priority for most healthcare facilities has been managing and treating COVID-19 patients. However, while this is going on, there are reports of reduced volumes... Read more

Cardiology Management

Onco-Cardiology: Consensus Paper from Germany

2020 27 May

There is sufficient clinical evidence to show that the use of certain chemotherapeutic drugs is associated with cardiac toxicity. In many cases, the impairment in cardiac dysfunction caused by these drugs is lifelong and can severely impair the quality of life of patients. While many drugs continue to be approved to treat malignancies, the cardiac... Read more

Cardiology Management

COVID-19: Dangerous Cardiovascular Complications

2020 18 May

COVID-19 can cause serious cardiovascular complications including heart failure, heart attacks and blood clots that can lead to strokes, emergency medicine doctors report in a new scientific paper. They also caution that COVID-19 treatments can interact with medicines used to manage patients' existing cardiovascular conditions. The new paper from... Read more

Health Management

Volume 20 - Issue 3, 2020

2020 11 May

Change content default value Read more